High level expression of recombinant porcine coagulation factor VIII

被引:86
作者
Doering, CB [1 ]
Healey, JF [1 ]
Parker, ET [1 ]
Barrow, RT [1 ]
Lollar, P [1 ]
机构
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M206959200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant human factor VIII expression levels, in vitro and in vivo, are significantly lower than levels obtained for other recombinant coagulation proteins. Here we describe the generation, high level expression and characterization of a recombinant B-domain-deleted porcine factor VIII molecule. Recombinant B-domain-deleted porcine factor VIII expression levels are 10- to 14-fold greater than recombinant B-domain-deleted human factor VIII levels by transient and stable expression in multiple cell lines. Peak expression of 140 units.10(6) cells(-1).24 h(-1) was observed from a baby hamster kidney-derived cell line stably expressing recombinant porcine factor VIII. Factor VIII expression was performed in serum-free culture medium and in the absence of exogenous von Willebrand factor, thus greatly simplifying protein purification. Real time reverse transcription-PCR analysis demonstrated that the differences in protein production were not caused by differences in steady-state factor VIII mRNA levels. The identification of sequence(s) in porcine factor VIII responsible for high level expression may lead to a better understanding of the mechanisms that limit factor VIII expression.
引用
收藏
页码:38345 / 38349
页数:5
相关论文
共 39 条
[1]   Antigenicity of putative phospholipid membrane-binding residues in factor VIII [J].
Barrow, RT ;
Healey, JF ;
Jacquemin, MG ;
Saint-Remy, JMR ;
Lollar, P .
BLOOD, 2001, 97 (01) :169-174
[2]   Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules [J].
Barrow, RT ;
Healey, JF ;
Gailani, D ;
Scandella, D ;
Lollar, P .
BLOOD, 2000, 95 (02) :564-568
[3]   DEVELOPMENT AND ANALYSIS OF RETROVIRAL VECTORS EXPRESSING HUMAN FACTOR-VIII AS A POTENTIAL GENE-THERAPY FOR HEMOPHILIA-A [J].
CHUAH, MKL ;
VANDENDRIESSCHE, T ;
MORGAN, RA .
HUMAN GENE THERAPY, 1995, 6 (11) :1363-1377
[4]  
CURTIS JE, 1994, J BIOL CHEM, V269, P6246
[5]   The interaction of the calcium- and integrin-binding protein (CIBP) with the coagulation factor VIII [J].
Fang, XD ;
Chen, C ;
Wang, Q ;
Gu, JX ;
Chi, CW .
THROMBOSIS RESEARCH, 2001, 102 (02) :177-185
[6]  
FAY PJ, 1992, J BIOL CHEM, V267, P13246
[7]   EXPRESSION OF THE AMINO-TERMINAL HALF-MOLECULE OF HUMAN SERUM TRANSFERRIN IN CULTURED-CELLS AND CHARACTERIZATION OF THE RECOMBINANT PROTEIN [J].
FUNK, WD ;
MACGILLIVRAY, RTA ;
MASON, AB ;
BROWN, SA ;
WOODWORTH, RC .
BIOCHEMISTRY, 1990, 29 (06) :1654-1660
[8]   rFactor VIII deficit questioned [J].
Garber, K .
NATURE BIOTECHNOLOGY, 2000, 18 (11) :1133-1133
[9]  
GATTI L, 1984, THROMB HAEMOSTASIS, V51, P379
[10]   CHARACTERIZATION OF THE HUMAN FACTOR-VIII GENE [J].
GITSCHIER, J ;
WOOD, WI ;
GORALKA, TM ;
WION, KL ;
CHEN, EY ;
EATON, DH ;
VEHAR, GA ;
CAPON, DJ ;
LAWN, RM .
NATURE, 1984, 312 (5992) :326-330